Search research articles
Contact Us
Filters
Showing results (131-140 of 160) with videos related to
Page
of 16
Sort By:
Scientific Reports
|
February 6, 2019
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Sarah A Milgrom, Hesham Elhalawani, Joonsang Lee, et al.
Leukemia & Lymphoma
|
May 4, 2021
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy
Karine A Al Feghali, Penny Fang, Maria Gule-Monroe, et al.
British Journal of Haematology
|
January 31, 2021
Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis
Paolo Strati, Phoebe T M Cheng, Raphael E Steiner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 29, 2021
Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study
Suman Shrestha, James E Bates, Qi Liu, et al.
British Journal of Haematology
|
September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant
Hua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
Leukemia & Lymphoma
|
January 22, 2021
The impact of cell-of-origin, MYC/Bcl-2 dual expression and <i>MYC</i> rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
Alexander Augustyn, L Jeffrey Medeiros, Ethan B Ludmir, et al.
Blood Advances
|
June 14, 2018
Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL
Chelsea C Pinnix, Andrea K Ng, Bouthaina S Dabaja, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2018
Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma
Sarah A Milgrom, Chelsea C Pinnix, T Linda Chi, et al.
Blood Advances
|
May 1, 2019
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Chelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 160) with videos related to
Sort By:
Page
of 16
Scientific Reports
|
February 6, 2019
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Sarah A Milgrom, Hesham Elhalawani, Joonsang Lee, et al.
Leukemia & Lymphoma
|
May 4, 2021
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy
Karine A Al Feghali, Penny Fang, Maria Gule-Monroe, et al.
British Journal of Haematology
|
January 31, 2021
Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis
Paolo Strati, Phoebe T M Cheng, Raphael E Steiner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 29, 2021
Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study
Suman Shrestha, James E Bates, Qi Liu, et al.
British Journal of Haematology
|
September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant
Hua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
Leukemia & Lymphoma
|
January 22, 2021
The impact of cell-of-origin, MYC/Bcl-2 dual expression and <i>MYC</i> rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
Alexander Augustyn, L Jeffrey Medeiros, Ethan B Ludmir, et al.
Blood Advances
|
June 14, 2018
Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL
Chelsea C Pinnix, Andrea K Ng, Bouthaina S Dabaja, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2018
Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma
Sarah A Milgrom, Chelsea C Pinnix, T Linda Chi, et al.
Blood Advances
|
May 1, 2019
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Chelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, et al.
Page
of 16